Pfizer Oncology

Pfizer OncologyTORISEL is an mTOR inhibitor indicated for the treatment of renal cell carcinoma (RCC), a cancer of the kidney. The key to good pharmaceutical marketing is rooted in the science of the product and the data that indicate promise for the patient.